Search results
Found 69 matches for
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
©
Shutterstock
£1.4m awarded to investigate how tumour mechanics affect the immune response to cancer
24 June 2025
Professor Marco Fritzsche from the Kennedy Institute of Rheumatology, is co-leading a research project that has been awarded a £1.4 million Programme Foundation Award from Cancer Research UK, to investigate how physical forces within tumours affect the ability of a type of white blood cell to attack and eliminate cancer cells.
CRUK funding for research into earlier detection of relapse in people with multiple myeloma
23 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
NDORMS leads study on burosumab for adults with rare inherited disorder
10 April 2025
NDORMS researchers have been awarded funding to explore the long-term effects of burosumab in adults with X-linked hypophosphataemia (XLH).
NDORMS receives funding to tackle the global burden of musculoskeletal injuries
27 February 2025
A grant from the National Institute for Health and Care Research (NIHR) is funding a study to improve healthcare treatment and care for patients with broken bones in three Sub-Saharan Africa countries.
Stephanie Dakin awarded a Versus Arthritis Bridging Fellowship
29 January 2025
Professor Stephanie Dakin has been awarded a Versus Arthritis Bridging Fellowship to advance the work of her Versus Arthritis sponsored Career Development Fellowship investigating frozen shoulder.
Translational funding enables preclinical trial of new treatment for torn ACL injuries
2 October 2024
NDORMS researchers have received funding from the Medical Research Council (MRC) to explore a new treatment for anterior cruciate ligament (ACL) injuries which could provide relief for thousands of young people suffering from knee pain.
NDORMS joins the Human Functional Genomics Initiative
19 August 2024
£28.5m in funding has been announced to support functional genomics research across the UK, including a research cluster at NDORMS that will deliver insights into musculoskeletal health and disease.
Simon Matthew Graham awarded an MRC Clinician Scientist Fellowship
26 March 2024
The award from the Medical Research Council (MRC) will support research to improve treatments for open fractures in low- and middle-income countries.
CRUK funding success for Audrey Gérard
14 February 2024
Audrey Gérard has received £ 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
Data-Driven research will map COVID-19 vaccine effectiveness in Brazil and Pakistan
5 April 2023
A study to monitor the safety and effectiveness of the COVID-19 vaccine in the Global South, has received funding from the Bill & Melinda Gates Foundation’s Grand Challenges initiative.
NIHR funding for musculoskeletal and inflammatory disease research
17 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
MRC funding awarded to Kennedy researchers
8 September 2022
Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
Oxford receives NIHR funding to test anti-TNF on post operative delirium
27 July 2022
Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.
Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases
5 July 2022
A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.
Oxford researchers awarded funding to study the immune response to malaria
15 March 2022
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”
Funding boost for early-stage clinical research
8 March 2022
Oxford is one of 28 sites that will benefit from over £160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
New funding awarded to study persistent pain in inflammatory arthritis
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative
17 November 2021
The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.
Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map
12 November 2021
NDORMS researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.
New advanced analytics research to deliver next level of insights into COVID-19
11 November 2021
NDORMS is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.
MEET FIONA
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
FUNDED BY
Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2
Journal of Experimental Medicine